Literature DB >> 24078559

Older individuals with HIV infection have greater memory deficits than younger individuals.

I Lin Tan, B R Smith, Edward Hammond, Heidi Vornbrock-Roosa, Jason Creighton, O Selnes, Justin C McArthur, Ned Sacktor.   

Abstract

The prevalence of HIV-associated neurocognitive disorder (HAND) remains persistently high in the era of combination antiretroviral therapy. We aimed to characterize the pattern of neurocognitive dysfunction in older subjects with HAND in particular amnestic versus non-amnestic impairment. One hundred six subjects from the Johns Hopkins University NIMH Clinical Outcomes cohort underwent standardized neuropsychological (NP) testing between November 2006 and June 2010. We examined performance in seven cognitive domains (memory, attention, speed of processing,visuospatial, language, motor, and executive). Older subjects were defined as age >50 years at the time of NP testing.Subjects were diagnosed with HAND according to established criteria and dichotomized into amnestic cognitive impairment or non-amnestic cognitive impairment with deficit defined as z scores <−1.5 for the verbal and nonverbal memory domains.There were 32 older subjects with a mean age (SD) of 54.2 (2.8) years and 74 younger subjects, 43.7 (4.3) years. Older age was associated with a 4.8-fold higher odds of memory deficits adjusted for potential confounders (p =0.035) identified a priori. With age modeled as a continuous covariate,every 1 year increase in age was associated with a 1.11-fold higher odds of memory deficit (p =0.05). There was a higher proportion of amnestic cognitive impairment among older subjects than younger subjects with HIV infection. Neurodegenerative processes other than those directly due to HIV maybe increasingly important as individuals with chronic HIV infection and HAND survive into older age.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24078559      PMCID: PMC3946697          DOI: 10.1007/s13365-013-0209-3

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  18 in total

Review 1.  Human immunodeficiency virus-associated neurocognitive disorders: Mind the gap.

Authors:  Justin C McArthur; Joseph Steiner; Ned Sacktor; Avi Nath
Journal:  Ann Neurol       Date:  2010-06       Impact factor: 10.422

2.  HIV-associated central nervous system diseases in the era of combination antiretroviral therapy.

Authors:  I L Tan; J C McArthur
Journal:  Eur J Neurol       Date:  2010-12-15       Impact factor: 6.089

Review 3.  Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.

Authors:  Chen S Tan; Igor J Koralnik
Journal:  Lancet Neurol       Date:  2010-04       Impact factor: 44.182

4.  Sex differences in interhemispheric reorganization of speech.

Authors:  E Strauss; J Wada; B Goldwater
Journal:  Neuropsychologia       Date:  1992-04       Impact factor: 3.139

5.  HIV-associated cognitive impairment before and after the advent of combination therapy.

Authors:  Ned Sacktor; Michael P McDermott; Karen Marder; Giovanni Schifitto; Ola A Selnes; Justin C McArthur; Yaakov Stern; Steve Albert; Donna Palumbo; Karl Kieburtz; Joy A De Marcaida; Bruce Cohen; Leon Epstein
Journal:  J Neurovirol       Date:  2002-04       Impact factor: 2.643

6.  Prevalence of cognitive impairment: data from the Indianapolis Study of Health and Aging.

Authors:  F W Unverzagt; S Gao; O Baiyewu; A O Ogunniyi; O Gureje; A Perkins; C L Emsley; J Dickens; R Evans; B Musick; K S Hall; S L Hui; H C Hendrie
Journal:  Neurology       Date:  2001-11-13       Impact factor: 9.910

7.  Importance of subtle amnestic and nonamnestic deficits in mild cognitive impairment: prognosis and conversion to dementia.

Authors:  S D Rountree; S C Waring; W C Chan; P J Lupo; E J Darby; R S Doody
Journal:  Dement Geriatr Cogn Disord       Date:  2007-11-08       Impact factor: 2.959

Review 8.  Cognitive impairment in older HIV-1-seropositive individuals: prevalence and potential mechanisms.

Authors:  Victor G Valcour; Cecilia M Shikuma; Michael R Watters; Ned C Sacktor
Journal:  AIDS       Date:  2004-01-01       Impact factor: 4.177

9.  Gender differences in the relationship of ENPP1/PC-1 variants to obesity in a Turkish population.

Authors:  Sinan Tanyolaç; Robert W Mahley; Uğur Hodoglugil; Ira D Goldfine
Journal:  Obesity (Silver Spring)       Date:  2008-08-21       Impact factor: 5.002

10.  The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics.

Authors:  Rosebud O Roberts; Yonas E Geda; David S Knopman; Ruth H Cha; V Shane Pankratz; Bradley F Boeve; Robert J Ivnik; Eric G Tangalos; Ronald C Petersen; Walter A Rocca
Journal:  Neuroepidemiology       Date:  2008-02-07       Impact factor: 3.282

View more
  13 in total

1.  Effect of ageing on neurocognitive function by stage of HIV infection: evidence from the Multicenter AIDS Cohort Study.

Authors:  Karl Goodkin; Eric N Miller; Christopher Cox; Sandra Reynolds; James T Becker; Eileen Martin; Ola A Selnes; David G Ostrow; Ned C Sacktor
Journal:  Lancet HIV       Date:  2017-07-14       Impact factor: 12.767

2.  Impact of aging on neurocognitive performance in previously antiretroviral-naive HIV-infected individuals on their first suppressive regimen.

Authors:  Hamza Coban; Kevin Robertson; Marlene Smurzynski; Supriya Krishnan; Kunling Wu; Ronald J Bosch; Ann C Collier; Ronald J Ellis
Journal:  AIDS       Date:  2017-07-17       Impact factor: 4.177

Review 3.  Childhood maltreatment and HIV-associated neurocognitive disorders share similar pathophysiology: a potential sensitisation mechanism?

Authors:  Jacqueline S Womersley; Soraya Seedat; Sian M J Hemmings
Journal:  Metab Brain Dis       Date:  2017-07-05       Impact factor: 3.584

4.  The current understanding of overlap between characteristics of HIV-associated neurocognitive disorders and Alzheimer's disease.

Authors:  Leah H Rubin; Erin E Sundermann; David J Moore
Journal:  J Neurovirol       Date:  2019-01-22       Impact factor: 2.643

Review 5.  Heterogeneity of Neuropsychological Impairment in HIV Infection: Contributions from Mild Cognitive Impairment.

Authors:  Kathryn N Devlin; Tania Giovannetti
Journal:  Neuropsychol Rev       Date:  2017-05-24       Impact factor: 7.444

Review 6.  Targeting Cannabinoid Receptor 2 on Peripheral Leukocytes to Attenuate Inflammatory Mechanisms Implicated in HIV-Associated Neurocognitive Disorder.

Authors:  Michael D Rizzo; Joseph E Henriquez; Lance K Blevins; Anthony Bach; Robert B Crawford; Norbert E Kaminski
Journal:  J Neuroimmune Pharmacol       Date:  2020-05-14       Impact factor: 4.147

7.  Differential Effects of Antiretroviral Drugs on Neurons In Vitro: Roles for Oxidative Stress and Integrated Stress Response.

Authors:  Anna L Stern; Rebecca N Lee; Nina Panvelker; Jiean Li; Jenna Harowitz; Kelly L Jordan-Sciutto; Cagla Akay-Espinoza
Journal:  J Neuroimmune Pharmacol       Date:  2017-08-31       Impact factor: 4.147

8.  Impairments in Component Processes of Executive Function and Episodic Memory in Alcoholism, HIV Infection, and HIV Infection with Alcoholism Comorbidity.

Authors:  Rosemary Fama; Edith V Sullivan; Stephanie A Sassoon; Adolf Pfefferbaum; Natalie M Zahr
Journal:  Alcohol Clin Exp Res       Date:  2016-10-19       Impact factor: 3.455

Review 9.  Interactions between ageing and NeuroAIDS.

Authors:  Joanna Hellmuth; Benedetta Milanini; Victor Valcour
Journal:  Curr Opin HIV AIDS       Date:  2014-11       Impact factor: 4.283

Review 10.  Evolving clinical phenotypes in HIV-associated neurocognitive disorders.

Authors:  Ned Sacktor; Kevin Robertson
Journal:  Curr Opin HIV AIDS       Date:  2014-11       Impact factor: 4.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.